Effect of Pulsatile Hormone Administration on Insulin Action
Pennington Biomedical Research Center
12 participants
Mar 4, 2024
INTERVENTIONAL
Conditions
Summary
In humans, insulin is secreted in pulses from the pancreatic beta-cells, and these oscillations help to maintain fasting plasma glucose levels within a narrow normal range. Given the fluctuations in insulin concentrations, oscillations enhance precision of control. The hyperinsulinemic euglycemic clamp test (clamp) involves a continuous infusion of insulin and is the gold standard for measuring insulin sensitivity. In this study, insulin sensitivity measured using the standard clamp will be compared with a clamp in which the same total amount of insulin as the standard clamp is infused every five minutes instead of continuously.
Eligibility
Inclusion Criteria1
- Completion of the Motivate Study (NCT05649176)
Exclusion Criteria1
- Non-completion of the end-of-study hyperinsulinemic euglycemic clamp test of the Motivate study
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will receive insulin delivered continuously during the hyperinsulinemic euglycemic clamp test
Participants will receive insulin delivered every five minutes during the hyperinsulinemic euglycemic clamp test
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06216665